149 related articles for article (PubMed ID: 2460487)
21. 5 alpha-reductase inhibition by finasteride (Proscar) in epithelium and stroma of human benign prostatic hyperplasia.
Weisser H; Tunn S; Debus M; Krieg M
Steroids; 1994 Nov; 59(11):616-20. PubMed ID: 7535480
[TBL] [Abstract][Full Text] [Related]
22. [Androgen and estrogen metabolism in human benign prostatic hyperplasia (BPH)].
Krieg M; Weisser H; Tunn S
Verh Dtsch Ges Pathol; 1993; 77():19-24. PubMed ID: 7511279
[TBL] [Abstract][Full Text] [Related]
23. 5 alpha-reductase activity in stroma and epithelium of rat prostate and epididymis. A contribution to elucidation of the mechanism for development of hyperplastic growth of prostatic tissue.
Djøseland O; Bruchovsky N; Rennie PS; Otal N; Høglo S
Acta Endocrinol (Copenh); 1983 Jun; 103(2):273-81. PubMed ID: 6190338
[TBL] [Abstract][Full Text] [Related]
24. Alteration in the metabolism of dihydrotestosterone in elderly men with prostate hyperplasia.
Morimoto I; Edmiston A; Horton R
J Clin Invest; 1980 Sep; 66(3):612-5. PubMed ID: 6156957
[TBL] [Abstract][Full Text] [Related]
25. Cell kinetic in epithelium and stroma of benign prostatic hyperplasia.
Claus S; Berges R; Senge T; Schulze H
J Urol; 1997 Jul; 158(1):217-21. PubMed ID: 9186363
[TBL] [Abstract][Full Text] [Related]
26. Stromal 5 alpha-reductase activity is elevated in benign prostatic hyperplasia.
Wilkin RP; Bruchovsky N; Shnitka TK; Rennie PS; Comeau TL
Acta Endocrinol (Copenh); 1980 Jun; 94(2):284-8. PubMed ID: 6158242
[TBL] [Abstract][Full Text] [Related]
27. Dihydrotestosterone accumulation in genital skin fibroblasts derived from elderly men with prostatic hyperplasia.
Morimoto I; Eto S; Inoue S; Izumi M; Hara T; Saito Y; Nagataki S
J Clin Endocrinol Metab; 1992 Aug; 75(2):632-5. PubMed ID: 1379259
[TBL] [Abstract][Full Text] [Related]
28. Three-month treatment with a long-acting gonadotropin-releasing hormone agonist of patients with benign prostatic hyperplasia: effects on tissue androgen concentration, 5 alpha-reductase activity and androgen receptor content.
Forti G; Salerno R; Moneti G; Zoppi S; Fiorelli G; Marinoni T; Natali A; Costantini A; Serio M; Martini L
J Clin Endocrinol Metab; 1989 Feb; 68(2):461-8. PubMed ID: 2465302
[TBL] [Abstract][Full Text] [Related]
29. Studies of the nuclear 5 alpha-reductase of human prostatic tissue: comparison of enzyme activities in hyperplastic, malignant, and normal tissues.
Hudson RW; Moffitt PM; Owens WA
Can J Biochem Cell Biol; 1983 Jul; 61(7):750-5. PubMed ID: 6194868
[TBL] [Abstract][Full Text] [Related]
30. [Androgen receptor and 5 alpha-reductase activity in the epithelium and the stroma of human benign prostatic hyperplasia].
Oishi K; Okada K; Yoshida O; Romijn JC; Bolt de Vries J; Schröder FH
Hinyokika Kiyo; 1985 May; 31(5):785-90. PubMed ID: 2413745
[TBL] [Abstract][Full Text] [Related]
31. Comparison of testosterone metabolism in benign prostatic hyperplasia and human prostate cancer cell lines in vitro.
Smith CM; Ballard SA; Wyllie MG; Masters JR
J Steroid Biochem Mol Biol; 1994 Aug; 50(3-4):151-9. PubMed ID: 7519439
[TBL] [Abstract][Full Text] [Related]
32. [Measurement of T and DHT contents in normal and diseased human prostate tissues].
Zhang Y; Ye L; Ding Q; Fang Z; Yao M; Shi D
Zhonghua Wai Ke Za Zhi; 2000 Jul; 38(7):545-7. PubMed ID: 11832106
[TBL] [Abstract][Full Text] [Related]
33. Lovastatin-induced apoptosis in prostate stromal cells.
Padayatty SJ; Marcelli M; Shao TC; Cunningham GR
J Clin Endocrinol Metab; 1997 May; 82(5):1434-9. PubMed ID: 9141529
[TBL] [Abstract][Full Text] [Related]
34. 17 beta-Hydroxysteroid dehydrogenase in the human prostate: properties and distribution between epithelium and stroma in benign hyperplastic tissue.
Bartsch W; Greeve J; Voigt KD
J Steroid Biochem; 1987 Jul; 28(1):35-42. PubMed ID: 2441144
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of MENT on primary cell cultures from benign prostatic hyperplasia and prostate carcinoma.
Mendoza P; Sánchez C; Contreras HR; Vergara J; Acevedo C; Cabezas J; Huidobro C; Noé G; Castellón EA
Int J Androl; 2009 Dec; 32(6):607-15. PubMed ID: 18637152
[TBL] [Abstract][Full Text] [Related]
36. Effects of the sabal serrulata extract IDS 89 and its subfractions on 5 alpha-reductase activity in human benign prostatic hyperplasia.
Weisser H; Tunn S; Behnke B; Krieg M
Prostate; 1996 May; 28(5):300-6. PubMed ID: 8610056
[TBL] [Abstract][Full Text] [Related]
37. Enzyme activities in tissue of human benign prostatic hyperplasia after three months' treatment with the Sabal serrulata extract IDS 89 (Strogen) or placebo.
Weisser H; Behnke B; Helpap B; Bach D; Krieg M
Eur Urol; 1997; 31(1):97-101. PubMed ID: 9032543
[TBL] [Abstract][Full Text] [Related]
38. Effect of finasteride, a 5 alpha-reductase inhibitor on prostate tissue androgens and prostate-specific antigen.
Geller J
J Clin Endocrinol Metab; 1990 Dec; 71(6):1552-5. PubMed ID: 1699965
[TBL] [Abstract][Full Text] [Related]
39. The distribution of 5 alpha-reductase and 3 alpha(beta)-hydroxysteroid dehydrogenase activities in the hyperplastic human prostate gland.
Habib FK; Beynon L; Chisholm GD; Busuttil A
Steroids; 1983 Jan; 41(1):41-53. PubMed ID: 6197780
[TBL] [Abstract][Full Text] [Related]
40. Changes in dihydrotestosterone metabolism associated with the development of canine benign prostatic hyperplasia.
Isaacs JT; Coffey DS
Endocrinology; 1981 Feb; 108(2):445-53. PubMed ID: 6161001
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
